Milestone Pharmaceuticals MIST
NASDAQ MIST
$0.70 -0.02 (-2.69%)
As of: Oct 21, 2026 · 3:49 PM EDT

Milestone Pharmaceuticals (MIST) Revenue (2021 - 2023)

Updated

Milestone Pharmaceuticals' Revenue came in at $1.5 million for Q3 2022.

Analysis

Milestone Pharmaceuticals (MIST) Revenue (2021 - 2023) Analysis & Trends

Over the trailing twelve months to Sep 30, 2022, Milestone Pharmaceuticals reported Revenue of $16.5 million; for FY2021, it was $15 million.

  • The Q3 2022 figure represents the highest quarterly Revenue since Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,138.83 Bn 1,107.41 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 618.88 Bn 537.41 Bn 17.26 Bn 25.31 Bn
3 AbbVie 502.93 Bn 476.04 Bn 12.70 Bn 16.99 Bn
4 Merck 369.61 Bn 323.99 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 298.70 Bn 262.69 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.59 Bn 192.99 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 191.60 Bn 165.79 Bn 6.22 Bn 7.80 Bn
9 Pfizer 170.23 Bn 116.88 Bn 10.94 Bn 15.03 Bn
10 Milestone Pharmaceuticals 97.08 Mn -73.52 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 552,000.00
Dec 31, 2022 582,000.00
Sep 30, 2022 1.50 Mn
Jun 30, 2022 158,000.00
Mar 31, 2022 40,000.00
Jun 30, 2021 15.00 Mn
API Access

Milestone Pharmaceuticals Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=MIST&period=max&api_key=YOUR_API_KEY